drugset
drugset / Trial / NCT01018446

Hematopoietic Stem Cell Transplantation Based on Pharmacokinetic and Pharmacodynamic Modeling

NCT01018446 ↗

Phase 1 Completed 30 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

In this study the investigators plan to develop a method to determine optimal busulfan dose through pharmacokinetic study.

Timeline

Start
2008-12
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Busulfan Small molecule 80 mg/m2 Intravenous
Subject Busulfan Small molecule 120 mg/m2 Intravenous

Indications

disease related to hematopoietic stem cell transplant